Literature DB >> 15696126

Quantitation of CDC6 and MCM5 mRNA in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix.

Niamh Murphy1, Martina Ring, Cynthia C B B Heffron, Cara M Martin, Eamon McGuinness, Orla Sheils, John J O'Leary.   

Abstract

CDC6 and MCM5 play essential roles in eukaryotic DNA replication. Several studies have highlighted the potential of these proteins as molecular markers of dysplastic and malignant cells in histopathological diagnosis. The mode of expression of CDC6 and MCM5 mRNA and their significance in normal, dysplastic and malignant cervical cells remains to be elucidated. Using a quantitative real-time RT PCR assay, we compared CDC6 and MCM5 mRNA expression in normal cervical epithelium, cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix. Our study cohort comprised 20 normal cervical biopsies, 20 CIN3 and eight invasive squamous cell carcinomas. All samples were formalin fixed and paraffin embedded. Total RNA was extracted and analysed for expression of GAPDH, CDC6 and MCM5 using real-time quantitative TaqMan RT-PCR. A linear increase in MCM5 and CDC6 mRNA expression is observed in normal cervix, CIN3 and invasive cervical carcinoma. The overall difference in MCM5 mRNA expression in the normal cervix, CIN3 and invasive cohort groups is highly statistically significant (P=0.001). An increase in CDC6 mRNA expression in CIN3 and invasive cervical squamous cell carcinoma was observed; however, the overall difference between cohort groups was not found to be statistically significant (P=0.104). Increased transcription of MCM5 and CDC6 occurs as a consequence of cervical neoplastic progression. This pattern of increased mRNA expression in CIN3 and invasive cervical carcinoma directly correlates with findings at the phenotypic protein expression level. This study further confirms the importance of MCM5 and CDC6 in malignant transformation and in the pathogenesis of cervical dysplasia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15696126     DOI: 10.1038/modpathol.3800361

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  14 in total

Review 1.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.

Authors:  Vikrant V Sahasrabuddhe; Patricia Luhn; Nicolas Wentzensen
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

2.  MCM5 promotes tumour proliferation and correlates with the progression and prognosis of renal cell carcinoma.

Authors:  Binbin Gong; Ming Ma; Xiaorong Yang; Wenjie Xie; Yanping Luo; Ting Sun
Journal:  Int Urol Nephrol       Date:  2019-06-12       Impact factor: 2.370

3.  Role of Cdc6 in re-replication in cells expressing human papillomavirus E7 oncogene.

Authors:  Xueli Fan; Yunying Zhou; Jason J Chen
Journal:  Carcinogenesis       Date:  2016-05-06       Impact factor: 4.944

Review 4.  Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.

Authors:  Cara M Martin; Louise Kehoe; Cathy O Spillane; John J O'Leary
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

5.  Cdc7-Dbf4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation.

Authors:  Dorine Bonte; Charlotta Lindvall; Hongyu Liu; Karl Dykema; Kyle Furge; Michael Weinreich
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

6.  Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.

Authors:  Heather Griffin; Yasmina Soneji; Romy Van Baars; Rupali Arora; David Jenkins; Miekel van de Sandt; Zhonglin Wu; Wim Quint; Robert Jach; Krzysztof Okon; Hubert Huras; Albert Singer; John Doorbar
Journal:  Mod Pathol       Date:  2015-05-08       Impact factor: 7.842

7.  Re-replication of a centromere induces chromosomal instability and aneuploidy.

Authors:  Stacey L Hanlon; Joachim J Li
Journal:  PLoS Genet       Date:  2015-04-22       Impact factor: 5.917

8.  Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells.

Authors:  Sansan Chen; Xinglu Chen; Gui'e Xie; Yue He; Daoyu Yan; Dianpeng Zheng; Shi Li; Xinyang Fu; Yeping Li; Xiang Pang; Zhiming Hu; Hongwei Li; Wanlong Tan; Jinlong Li
Journal:  Oncotarget       Date:  2016-06-28

Review 9.  Molecular basis for advances in cervical screening.

Authors:  John Doorbar; Heather Cubie
Journal:  Mol Diagn       Date:  2005

Review 10.  Biomarkers of HIV-associated Cancer.

Authors:  Brian Thabile Flepisi; Patrick Bouic; Gerhard Sissolak; Bernd Rosenkranz
Journal:  Biomark Cancer       Date:  2014-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.